The president of the company that made an Ebola treatment given to two Americans said Wednesday that the drug maker hadnt expected to use it in humans this soon Mapp Biopharmaceutical Inc which makes the treatment called ZMapp had planned to start testing ZMapps safety in humans in clinical trials next year President Larry Zeitlin said in an email The company which has nine employees had been focused on making a limited amount of ZMapp for testing in animals which is why so little is available